TherOx (R) AO system: hyperoxemic perfusion for myocardial infarction

Parrella, A
Record ID 32006000642
Authors' recommendations: The TherOx aqueous oxygen (AO) System aims at recovering/reversing myocardial damage from an acute myocardial infarction (AMI). Although it is not yet available for commercial use outside of Europe, there is potential for this therapy to benefit a significant proportion of the Australian population. A subgroup analysis of a high level trial (level II evidence) indicated that this therapy may be safe and effective for patients with certain indications. It is therefore recommended that a Horizon Scanning report be conducted.
Project Status: Completed
Year Published: 2005
URL for published report: Not Available
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Infusions, Intra-Arterial
  • Myocardial Reperfusion
  • Coronary Circulation
  • Myocardial Infarction
  • Oxygen
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
Contact Email:
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.